Humanigen Inc (PK:HGEN)

Business Focus: Biopharmaceuticals

INK Ultra Money Free

Latest 10 SEC filings (by transaction date) for HGEN within the last 6 months [?]
Amended Filing      Footnote and/or Remark
As of 11:59pm ET June 1st, 2020
Filing
Date
Transaction
Date
Insider Name Ownership
Type
Securities Nature of transaction Volume or Value Price
May 22/20 May 20/20 Barliant Ronald Direct Ownership Common Stock, $0.001 par value A - Grant, award or other under Rule 16b-3(d) 26,847 $0.860
May 21/20 May 20/20 Durrant Cameron Direct Ownership Stock Option (Right to Buy) A - Grant, award or other under Rule 16b-3(d) 250,000 $0.860
Apr 7/20 Apr 2/20 Chappell Dale Indirect Ownership Convertible Note C - Conversion   $500,000.00
Apr 7/20 Apr 2/20 Chappell Dale Indirect Ownership Common Stock, $0.001 par value C - Conversion 1,583,333 $0.360
Apr 7/20 Apr 1/20 Savage Robert G. Direct Ownership Stock Option (Right to Buy) A - Grant, award or other under Rule 16b-3(d) 21,022 $1.20
Apr 7/20 Apr 1/20 Barliant Ronald Direct Ownership Stock Option (Right to Buy) A - Grant, award or other under Rule 16b-3(d) 15,340 $1.20
Apr 2/20 Apr 1/20 Savage Robert G. Direct Ownership Stock Option (Right to Buy) A - Grant, award or other under Rule 16b-3(d) 66,071 $1.20
Apr 2/20 Apr 1/20 Buxton Cheryl Direct Ownership Common Stock, $0.001 par value A - Grant, award or other under Rule 16b-3(d) 10,824 $1.20
Apr 2/20 Apr 1/20 Boehm Rainer J. Direct Ownership Common Stock, $0.001 par value A - Grant, award or other under Rule 16b-3(d) 13,750 $1.20
Apr 2/20 Apr 1/20 Barliant Ronald Direct Ownership Stock Option (Right to Buy) A - Grant, award or other under Rule 16b-3(d) 48,214 $1.20
Sign up or login above to see all SEC filings within the past 6 months.
Latest 10 SEC filings (by filing date) for HGEN within the last 6 months [?]
Amended Filing      Footnote and/or Remark
As of 11:59pm ET June 1st, 2020
Filing
Date
Transaction
Date
Insider Name Ownership
Type
Securities Nature of transaction Volume or Value Price
May 22/20 May 20/20 Barliant Ronald Direct Ownership Common Stock, $0.001 par value A - Grant, award or other under Rule 16b-3(d) 26,847 $0.860
May 21/20 May 20/20 Durrant Cameron Direct Ownership Stock Option (Right to Buy) A - Grant, award or other under Rule 16b-3(d) 250,000 $0.860
Apr 7/20 Apr 1/20 Savage Robert G. Direct Ownership Stock Option (Right to Buy) A - Grant, award or other under Rule 16b-3(d) 21,022 $1.20
Apr 7/20 Apr 1/20 Barliant Ronald Direct Ownership Stock Option (Right to Buy) A - Grant, award or other under Rule 16b-3(d) 15,340 $1.20
Apr 7/20 Apr 2/20 Chappell Dale Indirect Ownership Convertible Note C - Conversion   $500,000.00
Apr 7/20 Sep 20/18 Chappell Dale Indirect Ownership Convertible Note J - Other transaction $500,000 $500,000.00
Apr 7/20 Apr 2/20 Chappell Dale Indirect Ownership Common Stock, $0.001 par value C - Conversion 1,583,333 $0.360
Apr 2/20 Apr 1/20 Savage Robert G. Direct Ownership Stock Option (Right to Buy) A - Grant, award or other under Rule 16b-3(d) 66,071 $1.20
Apr 2/20 Apr 1/20 Buxton Cheryl Direct Ownership Common Stock, $0.001 par value A - Grant, award or other under Rule 16b-3(d) 10,824 $1.20
Apr 2/20 Apr 1/20 Boehm Rainer J. Direct Ownership Common Stock, $0.001 par value A - Grant, award or other under Rule 16b-3(d) 13,750 $1.20
Sign up or login above to see all SEC filings within the past 6 months.
Sign up or login above to see the past 6 months of filings sorted by insider. .
Get holdings trends & enhanced insider charts in PDF now

Twitter

Search (past week) for $HGEN

Competitors

Competitors with Recent Insider Filings
Allakos (OQ:ALLK)
ChemoCentryx (OQ:CCXI)
BioMarin Pharmaceutical (OQ:BMRN)